Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Irritable bowel syndrome (IBS) is a common and chronic gastrointestinal disorder. Probiotics may have the potential to impact the management of IBS; however, the results of trials are conflicting. This study aimed to investigate whether a mixture of lactobacilli probiotics could improve abdominal symptoms in patients with unconstipated IBS. Fifty Vietnamese patients with unconstipated IBS were randomly assigned to either the probiotics or placebo groups. During the intervention, participants took the probiotic supplement, named Foodis Lactobacillus, or placebo capsule once a day. Patients recorded their subject global assessment (SGA) weekly and were assessed with the visual analogue scale (VAS) during the 4-week study period. Patients with SGA score of 2 points or more or a decrease of more than 30% in VAS score were considered responders. Patients who responded weekly for more than 2 of the 4 weeks were considered overall responders. There was no significant difference in demographic characteristics between the groups. Overall responder rates of improvement of global IBS symptoms assessed by SGA score were significantly higher in the probiotics group (80.8%) than in the placebo group (45.8%) (p = 0.009). The overall responder rates assessed by VAS score were also higher in the probiotics group (69.2%, 41.7%, p = 0.048). There were no adverse events in either group during the study period. Our findings suggest that the new combination of Lactobacilli appears to be promising in the relief of abdominal symptoms in Vietnamese patients with unconstipated IBS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Effects of probiotics, prebiotics, and synbiotics on human health
Markowiak, P., & Śliżewska, K. (2017) · Nutrients · doi:10.3390/nu9091021 · Cited by 2,401 · cited 2×
“They also produce some substances that have an antibiotic effect by fermenting undigested carbohydrates and dietary fiber, producing organic acids [39].”
BackgroundPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · cited 1×
“The prevalence of IBS ranges from <5% up to 20% depending on the criteria used [1].”
BackgroundO’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384 · cited 1×
“This phenomenon may be due to cultural factors, degree of pain, socioeconomic conditions, and healthcare systems [19,20].”
BackgroundRifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036 · cited 1×
“Treating IBS is important because the symptoms cause impairment in health-related quality of life, leading to increased use of health resources and reduced work productivity [2].”
BackgroundProbiotics: effects on immunity
Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H., & Salminen, S. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.444s · Cited by 1,019 · cited 1×
“They increase the efficiency of the immunologic system, particularly intestinal IgA responses, and alleviation of intestinal inflammatory response [40].”
BackgroundFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.202 · Cited by 747 · cited 1×
“Several meta-analyses of randomized controlled trials found probiotics to be more superior to placebo in reducing overall IBS symptoms and abdominal pain [10,11].”
Background
Cited by
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Probiotics as Antibiotic Alternatives for Human and Animal Applications
Rabetafika, H. N., Razafindralambo, A., Ebenso, B., & Razafindralambo, H. L. (2023) · Encyclopedia · doi:10.3390/encyclopedia3020040 · Cited by 116
“plantarum Effective global relief of IBS symptoms and abdominal pain without significant adverse events [135]”
BackgroundGut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 78
Varesi, A., Deumer, U.-S., Ananth, S. V., & Ricevuti, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215077 · Cited by 72
Wu, Y., Li, Y., Zheng, Q., & Li, L. (2024) · Nutrients · doi:10.3390/nu16132114 · Cited by 81
Vincenzo, F. D., Puca, P., Lopetuso, L. R., Petito, V., Masi, L., Bartocci, B., Murgiano, M., Felice, M. D., Petronio, L., Gasbarrini, A., et al. (2022) · Nutrients · doi:10.3390/nu14132664 · Cited by 64
Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review
Chlebicz-Wójcik, A., & Śliżewska, K. (2021) · Biomolecules · doi:10.3390/biom11081154 · Cited by 60
“The results of this study indicate the ability of the preparation to reduce the severity of abdominal pain, which was similar to results obtained by Hong et al. (2009), Zhang et al. (2019), and Skrzydło-Radomańska et al. (2021) [116,124–126].”
BackgroundResultInfluentialXie, P., Luo, M., Deng, X., Fan, J., & Xiong, L. (2023) · Nutrients · doi:10.3390/nu15173856 · Cited by 50
Bai, T., Xu, Z., Xia, P.-J., Feng, Y., Liu, B., Liu, H., Chen, Y., Yan, G., Lü, B., Yan, Z., et al. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002147 · Cited by 37
“Besides, the selection criteria and the outcomes evaluation were strictly referred to the US Food and Drug Administration guidance for IBS-D (20).”
MethodAn Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps
Pop, O. L., Vodnar, D. C., Diaconeasa, Z. M., Istrati, M., Bințințan, A., Bintintan, V. V., Suharoschi, R., & Gabbianelli, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197359 · Cited by 35
“plantarum Capsule; 1/day for 4 weeks Effective in the global relief of IBS symptoms, and in relieving abdominal pain [102]”
BackgroundSabaté, J., & Iglicki, F. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i7.732 · Cited by 36
Effect of Heat-Killed Lactobacillus casei DKGF7 on a Rat Model of Irritable Bowel Syndrome
Seong, G., Lee, S., Min, Y. W., Jang, Y. S., Kim, H. S., Kim, E.-J., Park, S., Kim, C.-H., & Chang, D. K. (2021) · Nutrients · doi:10.3390/nu13020568 · Cited by 29
Self-citationChen, M., Lu, Y., Xie, C.-R., Wang, X., Feng, S., Xiao, X.-Y., & Zheng, H. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000658 · Cited by 40
Zhang, H., Zhang, Y., Zhang, Y., Jiang, Z., Cui, Y., & Wang, Q. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.118 · Cited by 27
Xie, C.-R., Tang, B., Shi, Y., Peng, W.-Y., Ye, K., Tao, Q., Yu, S., Zheng, H., & Chen, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.853011 · Cited by 34
“, 2021), seventeen trials assessed Lactobacillus (Nobaek et al., 2000; Niedzielin et al., 2001; Niv et al., 2005; Sinn et al., 2008; Farup et al., 2012; Ducrotte et al., 2012; Dapoigny et al., 2012; Murakami et al., 2012; Stevenson et al., 2014; Pedersen et al., 2014; Thijssen et al., 2016; Lyra et al., 2016; Shin et…”
BackgroundOh, J. H., Jang, Y. S., Kang, D., Kim, H. S., Kim, E.-J., Park, S.-Y., Kim, C., Min, Y. W., & Chang, D. K. (2022) · Gut and Liver · doi:10.5009/gnl210478 · Cited by 29
“14,33 L. paracasei also induces a significant decrease of the pro-inflammatory cytokine interleu-kin-15 and significant increase in short-chain fatty acids.”
Self-citationJung, K.-M., Kim, A., Lee, J., Cho, D., Seo, J., Jung, E. S., Kang, H., Roh, J., & Kim, W.-G. (2022) · Nutrients · doi:10.3390/nu14102015 · Cited by 28
van der Geest, A. M., Schukking, I., Brummer, R. J., van de Burgwal, L., & Larsen, O. F. A. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0123 · Cited by 23
Zhang, W. X., Shi, L., Zhou, M. S., Wu, J., & Shi, H. Y. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001758 · Cited by 29
Chen, Y., Li, Y., Wang, X., Wang, Z., Hou, J., Su, S., Zhong, W., Xu, X. J., Zhang, J., Wang, B., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i5.532 · Cited by 21
VanDusseldorp, T. A., Stratton, M. T., Bailly, A. R., Holmes, A. J., Alesi, M. G., Feito, Y., Mangine, G. T., Hester, G. M., Esmat, T. A., Barcala, M., et al. (2020) · Nutrients · doi:10.3390/nu12030654 · Cited by 16
Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
Dai, Y., Wu, Y., Li, R., Chen, W., Tang, C., Lu, L., & Hu, L. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i41.6488 · Cited by 22
Matsuura, N., Kanayama, M., Watanabe, Y., Yamada, H., Lili, L., & Torii, A. (2024) · Nutrients · doi:10.3390/nu16193333 · Cited by 20
“However, further studies are necessary to comprehensively evaluate the effect of these supplements.”
BackgroundWang, H., Chen, Y., Zhao, A., Shen, Z., & Zhang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1709060 · Cited by 21
Current perspectives on irritable bowel syndrome: a narrative review
Hojo, M., & Nagahara, A. (2022) · Journal of International Medical Research · doi:10.1177/03000605221126370 · Cited by 16
Umeano, L., Iftikhar, S., Alhaddad, S. F., Paulsingh, C. N., Riaz, M. F., Garg, G., & Mohammed, L. (2024) · Cureus · doi:10.7759/cureus.58306 · Cited by 18
“Similar findings were obtained in research by Oh et al. examining the impact of a probiotic capsule given once daily for four weeks to 50 patients with IBS-D [29].”
ResultZhang, Y., Wu, T., Chen, Z., Meng, Y., Zhu, Z., Wang, Q., Tian, J., Yi, D., Wang, L., Zhao, D., et al. (2021) · Animals · doi:10.3390/ani11051424 · Cited by 13
“Although many probiotics are currently used as feed additives, the actual effects of microecological agents prepared by different probiotics are different in animals [36,37].”
BackgroundAbdellah, S. A., Scanzi, J., Gal, C., Martin, M., Beck, M., & Ojetti, V. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247446 · Cited by 8
Prebióticos e probióticos na saúde e no tratamento de doenças intestinais: uma revisão integrativa
Marques, C. G., da Cruz, E. M. R. M., Bezerra, V. M., Costa, J. T. G., Lira, S. M., Holanda, M. O., da Silva, J. Y. G., Canabrava, N. D. V., da Silva, B. B., & Guedes, M. I. F. (2020) · Research Society and Development · doi:10.33448/rsd-v9i10.9071 · Cited by 11
Determination and Safety Aspects of Probiotic Cultures
Patra, F., & Duary, R. K. (2022) · Wiley eBooks · doi:10.1002/9781119702160.ch6 · Cited by 7
Zhao, X., Sun, C., Jin, M., Chen, J., Xing, L., Yan, J., Wang, H., Liu, Z., & Chen, W. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04340-22 · Cited by 6
“Some species are recognized as probiotics that can benefit human health (6, 7), inhibit Editor Junhua Li, BGI Group”
BackgroundAzad, F., Hamidianshirazi, M., Mazloomi, S. M., Shafiee, M., & Ekramzadeh, M. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3728 · Cited by 4
“Supplementation with probiotics has also been shown to improve malnutrition in other diseases such as inflammatory bowel syndrome and human immunodeficiency virus (HIV) (Kerac et al., 2009; Oh et al., 2019).”
BackgroundResultvan der Geest, A. M., Schukking, I., Brummer, R. J., Pieterse, H., van den Nieuwboer, M., van de Burgwal, L., & Larsen, O. F. A. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0124 · Cited by 4
Foods and supplements as probiotic delivery vehicles
Pimentel, T. C., da Costa, W. K. A., Chioda, D. T. P., Luiz, D. O. S. M., Sivieri, K., & Magnani, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89908-6.00005-4 · Cited by 2
Hashim, S., Wang, S., Burr, B., Tadwalkar, S., Mehta, R., & Gupta, A. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm25035 · Cited by 1
Exploring the Health Benefits of Probiotics: Current Insights and Therapeutic Applications
Chandrasekaran, S., & Manoharan, K. (2026) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3485 · Cited by 1
Biotic therapies for irritable bowel syndrome: current interventions
Wodarczyk, G., Winte, M. F., Mastellone, D., Singh, T., DeSipio, J., & Phadtare, S. (2026) · Gastroenterology report · doi:10.1093/gastro/goag062 · Cited by 1
Probiotics for gastrointestinal health and disease treatment
Lacerda, D. C., da Costa, P. C. T., do Nascimento, L. C. P., & Alves, J. L. D. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89908-6.00022-4 · Cited by 1
Gut Bacterial Dysbiosis and Its Clinical Implications
Archer, A. C. (2021) · Springer eBooks · doi:10.1007/978-981-33-6236-9_1 · Cited by 2
Angry Gut: Irritable Bowel Syndrome
Rajput, I. S., Zaidi, S. I. H., Jaffri, M. S. A., Hasib, S. W., & Razaq, K. (2022) · Journal of Bahria University Medical and Dental College · doi:10.51985/jbumdc2021112
Probotics: A Promising Solution for Irritable Bowel Syndrome (Ibs)
Shabnom, M., Datta, A., & Mitra, R. D. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44is6.2588
Wandala, A., Monis, M., Hussain, A., Hashim, M., Haider, R., Malallah, M. A. Y., Khalid, R., & Abukhater, N. A. K. S. N. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i3.822
Peres, Y. B., Lima, A. C. D., de Alvarenga, J. F. R., Bauab, T. M., & Cavallini, D. C. U. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109291
Probiotics: An Emerging Tool against Pathogenic Bacteria
Bur, D., Akinola, I. A., Adeleke, A. A., Ezika, E. K., Ezennubia, K. P., Abdul-karim, H., Sulemana, O. I. R., Sulemana, M. M. I., & Rowaiye, A. B. (2026) · European Journal of Biology · doi:10.26650/eurjbiol.2026.1781227
Metadata
- Authors
- Oh, J. H., Jang, Y. S., Kang, D., Chang, D. K., & Min, Y. W.
- Affiliations
- Samsung Medical Center (KR)
- Corresponding author
- Min, Yang Won
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-11-27
- Volume
- 11
- Issue
- 12
- Pages
- 2887
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6950464
- OpenAlex
- W2990905783
- Cited by
- 45
- References
- 46
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 3 · 2023: 8 · 2022: 16 · 2021: 6 · 2020: 5
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Agriculture, Food and Rural Affairs (MAFRA) (316061-3)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- irritable bowel syndrome, lactobacilli, probiotics, abdominal symptoms, symptom relief, probiotic safety, Vietnamese patients
- MeSH terms
- Adult, Double-Blind Method, Female, Humans, Lactobacillus, Male, Placebos, Quality of Life, Vietnam, Abdominal Pain, Treatment Outcome, Probiotics, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.